Share This Author
Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children
- M. Paulke-Korinek, P. Rendi-Wagner, M. Kundi, Renate Kronik, H. Kollaritsch
- MedicineThe Pediatric infectious disease journal
- 1 November 2009
The universal mass vaccination program against rotavirus led to a substantial decrease in the hospitalization rates of the target cohort of the immunization program in Austria within 18 months, which was observed compared to the era before the introduction of the vaccine.
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop
TropNetEurop data can contribute to the harmonization of European treatment policies by focusing on disease frequency, patient characteristics, place of infection, course of disease, treatment and differences between network-member countries.
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.
[Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].
A significant reduction in the incidence of diarrhea was observed, with success depending directly on the rigorous use of the preparation, and the medication can be classified as low on side effects.
Vaccines and vaccination against tick-borne encephalitis
- H. Kollaritsch, M. Paulke-Korinek, H. Holzmann, J. Hombach, B. Bjorvatn, A. Barrett
- MedicineExpert review of vaccines
- 1 September 2012
The WHO has recently issued recommendations on evidence-based use of TBE vaccines, however, more data are needed regarding safety, efficacy and long-term protection after vaccination.
Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases.
Sentinel surveillance of data collected prospectively since 1999 has begun within TropNetEurop, a European network focusing on imported infectious diseases, and data from Trop netEurop member sites can contribute to the understanding of the epidemiological and clinical findings regarding imported falciparum malaria.
Simple Histidine-Rich Protein 2 Double-Site Sandwich Enzyme-Linked Immunosorbent Assay for Use in Malaria Drug Sensitivity Testing
- H. Noedl, J. Bronnert, Kritsanai Yingyuen, Bernhard Attlmayr, H. Kollaritsch, M. Fukuda
- BiologyAntimicrobial Agents and Chemotherapy
- 1 August 2005
The ELISA uses two commercial monoclonal antibodies and provides a drastically cheaper alternative to the test kits previously used in the HRP2 drug sensitivity test and is simple to establish and perform.
A histidine-rich protein 2-based malaria drug sensitivity assay for field use.
- H. Noedl, Bernhard Attlmayr, W. Wernsdorfer, H. Kollaritsch, R. S. Miller
- Medicine, BiologyThe American journal of tropical medicine and…
- 1 December 2004
A histidine-rich protein 2 (HRP2)-based drug sensitivity assay for testing of fresh isolates of Plasmodium falciparum in the field, which further simplifies the handling and culturing of malaria parasites by omitting centrifugation, washing, the use of serum, and dilution with uninfected red blood cells.
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
The Intercell JE vaccine IC51 had a safety profile similar to that of placebo, together with the immunogenicity data from a recent phase 3 trial, form the basis of application for licensure of this vaccine.